How do you inject semaglutide at home?

Which three body sites are approved for semaglutide injection?

Semaglutide is given as a subcutaneous injection, meaning the needle goes into the fat layer directly beneath the skin rather than into muscle. Three areas of the body are specified in the labeling for FDA-approved semaglutide products such as Wegovy (semaglutide 2.4 mg):

• Lower abdomen. Aim at least 2 inches away from the belly button. The abdomen typically has enough subcutaneous fat to make injections comfortable and absorption consistent.
• Front of the thigh. The upper, front-facing portion of either thigh works well for self-injection, especially when the upper arm is difficult to see or reach.
• Outer upper arm. This third option is sometimes easier when a caregiver gives the injection, because it can be tricky to angle the pen and confirm the indicator window is visible when doing it yourself.

Never inject into skin that is tender, bruised, red, or hard. Avoid scar tissue and stretch marks, where absorption can be unpredictable. This article provides an educational overview only. Always follow the Instructions for Use (IFU) packaged with your specific medication and any training your prescribing provider or pharmacist has given you.

Why does rotating your injection site matter?

Rotating where you inject each week protects the skin and helps the medication absorb consistently. Injecting into the same spot repeatedly can cause lipodystrophy, a condition in which fat tissue under the skin thickens, hardens, or atrophies from repeated trauma. Because semaglutide is absorbed through that tissue, lipodystrophy can reduce how much medication actually reaches the bloodstream. A case report published in Pharmacotherapy documented hard, raised injection-site nodules in a patient using once-weekly semaglutide, illustrating why site health matters over time.

Rotation does not mean switching body regions every week. It means moving at least 1 inch from the previous puncture point, within the same region or across regions. You might use a slightly different spot in the lower abdomen one week, shift to the thigh the following week, and cycle back. What matters is that each spot has time to recover before the next injection lands nearby. If you notice a persistent hard lump at a site you use frequently, stop injecting there and tell your provider.

Autoinjector pen versus vial and syringe: which format will you use?

The delivery format depends on what your provider prescribes. FDA-approved semaglutide products come in prefilled injection devices. Compounded semaglutide, prepared by state-licensed compounding pharmacies, is not FDA-approved and has not been evaluated in clinical trials equivalent to those conducted for FDA-approved products such as Wegovy. It is typically dispensed as a multi-dose vial requiring a separate insulin syringe. The table below summarizes the key differences.

For a detailed look at the safety considerations around compounded formulations, see Is compounded semaglutide safe?

Step-by-step overview: using an autoinjector pen

The steps below are an educational overview only. The exact procedure for your product may differ. Always defer to the IFU included with your medication and to any training your provider or pharmacist has given you, rather than relying on general guidance.

1. Gather supplies. You need the pen, an alcohol swab, a gauze pad or clean cloth, and an approved sharps disposal container nearby before you begin.
2. Check the pen. Confirm the dose label matches your prescription. The solution visible through the inspection window should appear clear and colorless. Do not use a pen that looks cloudy, contains visible particles, or has passed its expiration date.
3. Let it warm up. Allow the pen to sit at room temperature for about 30 minutes. Injecting a cold liquid tends to be more uncomfortable.
4. Wash hands and clean the site. Wash hands thoroughly with soap and water. Wipe the chosen skin area with an alcohol swab and let it dry completely before proceeding.
5. Remove the cap. Pull it straight off and avoid touching the needle end to keep it sterile.
6. Inject. Press the pen firmly and squarely against the skin. Per the Wegovy Instructions for Use, keep pressing until the yellow indicator bar stops moving, which typically takes 5 to 10 seconds. Lifting the pen early may result in an incomplete dose.
7. Remove and dispose. Lift the pen away from the skin and place it immediately into your sharps container. Apply gentle pressure to the site with gauze; do not rub.

Step-by-step overview: drawing from a vial and syringe

This is an educational overview only. Your pharmacy's dispensing label and your provider's instructions take precedence. Measuring the wrong volume is the most common error with vial-and-syringe administration, so confirm your prescribed dose mark with your provider before the first injection.

1. Gather supplies. You need the vial, a new insulin syringe of the gauge and length specified by your provider, an alcohol swab, gauze, and a sharps container.
2. Clean the vial stopper. Wipe the rubber top with a fresh alcohol swab and let it dry.
3. Draw air, then medication. Pull the plunger back to the prescribed dose mark to draw air into the syringe. Insert the needle through the stopper, push the air in, then pull the plunger back to draw medication up to the correct mark.
4. Clear any air bubbles (see the next section). Point the syringe upward, tap the barrel gently, then press the plunger very slightly to push bubbles out. Redraw to the correct mark if needed.
5. Prepare the site. Wipe the injection area with an alcohol swab, let it dry, and gently pinch a small fold of skin.
6. Insert and inject. Your provider or pharmacist will demonstrate the correct insertion angle, pinching technique, and hold duration for your specific syringe and needle length. Follow those instructions and your pharmacy's dispensing label rather than general guidance - technique details vary by needle gauge, patient body composition, and prescribed volume.
7. Dispose immediately. Drop the entire syringe into the sharps container right away. Never recap a used needle by hand.

Are air bubbles in the syringe dangerous?

Small air bubbles in a subcutaneous syringe are not a medical emergency. When medication enters the fat layer under the skin, any trapped air is absorbed by surrounding tissue rather than reaching the bloodstream, so the risk differs substantially from intravenous injection. However, a larger bubble does mean less medication in the barrel, so the delivered dose will be lower than intended. That is worth correcting before injecting.

For vial-and-syringe users, point the syringe upward after drawing the dose, tap the barrel gently so bubbles rise toward the plunger, press the plunger very slightly to push them out, and re-draw to the correct mark. For single-dose autoinjector pens such as Wegovy, no priming or bubble removal is required: per the Wegovy Instructions for Use, the pen is factory pre-set and designed to deliver an accurate dose without any flow check by the user. For multi-dose pens such as Ozempic, a flow check is performed only before the first use of each new pen, per the prescribing information. If you are unsure about the correct procedure for your specific product, call your pharmacy before injecting.

How should you store semaglutide at home?

Storage rules differ slightly between products. The guidance below reflects manufacturer labeling for FDA-approved products. Compounded semaglutide vials carry their own expiration and storage requirements printed on the pharmacy label, which always take priority over general guidance.

Freezing damages the physical stability of the semaglutide formulation. The Wegovy prescribing information states explicitly: "Do not freeze Wegovy. Do not use Wegovy if it has been frozen." If a pen or vial has been accidentally frozen, do not inject it. Contact your pharmacy for replacement guidance. Store all medication in its original carton, out of direct sunlight and away from heat sources, and keep it out of reach of children.

How do you dispose of used needles safely?

The FDA recommends placing every used needle, syringe, and spent pen into an FDA-cleared sharps disposal container immediately after each use, before setting the device down. These containers are sold at most pharmacies and medical supply stores and are generally affordable.

If an FDA-cleared container is not available, a heavy-duty household plastic container (such as a laundry detergent jug) may be used, provided it is leak-resistant, remains upright during use, has a tight-fitting puncture-resistant lid, and is clearly labeled "Sharps: Do Not Recycle."

• Do not throw loose needles or spent pens directly into household trash.
• Do not place sharps in a recycling bin.
• Seal and replace the container when it is about three-quarters full to prevent accidental needlestick injuries from overfilling.
• Never recap a used needle by hand.

When the container is nearly full, follow your community's disposal guidelines. The Safe Needle Disposal hotline (1-800-643-1643), endorsed by the FDA, can direct you to a local drop-off site or mail-back program.

Bruising and skin reactions: what is normal?

Mild redness, slight swelling, or a small bruise at the injection site is common and usually clears within a few days to two weeks. Bruising happens when the needle passes near a small blood vessel in the subcutaneous layer, allowing a minor amount of blood to disperse into surrounding tissue. The color change as the body reabsorbs that blood is a normal healing process, not a sign something went wrong.

Several factors make bruising more likely: injecting the same spot repeatedly without adequate rotation, taking blood-thinning medications (including aspirin, ibuprofen, or prescription anticoagulants), or choosing an area with less subcutaneous fat. Allowing the medication to reach room temperature before injecting, rotating sites consistently, and applying gentle pressure (not rubbing) immediately after withdrawal all reduce the likelihood of bruising.

Contact your provider if a bruise is larger than about 2 inches, unusually painful, or accompanied by warmth, increasing redness, or pus, since those signs could point to infection or a more significant reaction. Hard lumps that persist at an injection site for more than a few weeks should also be reported, as they may signal lipodystrophy requiring a change in technique or site selection. For a broader picture of what to expect in the early weeks, see What should you expect in your first 90 days on a GLP-1?

What happens if you miss a weekly dose?

Because semaglutide is dosed only once per week, there is a window for recovery if you forget. Based on the Wegovy injectable prescribing information:

• If you notice the missed dose and your next scheduled dose is more than 2 days (48 hours) away, take the missed dose as soon as possible and then return to the regular weekly schedule.
• If the next scheduled dose is within 2 days, skip the missed dose entirely and resume on the usual planned day.
• Never take a double dose to make up for one you skipped. Two doses close together significantly raise the risk of nausea, vomiting, and other gastrointestinal side effects.
• If two or more consecutive doses have been missed, contact your provider before restarting. The Wegovy prescribing information advises following the dose escalation schedule again after a prolonged gap rather than returning immediately to the highest dose.

Note: the catch-up window differs by product. Ozempic carries a five-day window; the Wegovy injectable allows two days; tirzepatide products (Mounjaro, Zepbound) follow a separate schedule. If you are using compounded semaglutide (which is not FDA-approved and is distinct from Wegovy), follow the missed-dose instructions printed on your pharmacy dispensing label, which may specify a different window. When in doubt, call your pharmacist or provider for guidance specific to your prescription.

When should you contact your pharmacy or provider?

Reach out to your pharmacy or prescribing provider for any of the following:

• The solution in the pen or vial appears cloudy, discolored, or contains visible particles before use.
• The medication has been frozen or left at temperatures above 86°F beyond the time window on the label.
• You notice persistent skin changes such as hard lumps, skin indentation, or redness that does not resolve within about a week.
• You are unsure of your prescribed dose or how to measure it correctly from a vial.
• You have missed multiple doses in a row and are uncertain whether to restart at a lower titration step.
• You experience any symptom that concerns you after an injection, including severe pain at the site, hives, difficulty breathing, or a rapidly expanding area of redness and warmth.

For questions about how semaglutide compares to tirzepatide in terms of mechanism and dosing experience, Semaglutide vs tirzepatide: what is the difference? covers the key clinical distinctions. To understand how weight loss typically progresses after starting treatment, How fast does semaglutide work? summarizes the research timeline.